DHS 75.24(12)(a)(a) A service shall have written policies and procedures for referring patients to other service providers and for coordinating care with other providers. DHS 75.24(12)(b)(b) Policies and procedures shall include a description of follow-up activities to be completed to support that recommended care is received. DHS 75.24(13)(a)(a) Clinical staff of a service shall develop a treatment plan for each patient. DHS 75.24(13)(b)(b) A patient’s treatment plan shall represent an agreement between the service and the patient regarding needs identified in the clinical assessment, the patient’s identified treatment goals, and treatment interventions and resources to be applied. DHS 75.24(13)(c)(c) When feasible, the treatment plan shall be developed in collaboration and with input from the patient’s family or significant other, or other supportive persons identified by the patient. DHS 75.24(13)(d)(d) The treatment plan shall be signed by the patient, the primary counselor, and other behavioral health clinical staff, identified in the treatment plan. DHS 75.24(13)(e)(e) A treatment plan completed by a substance abuse counselor in-training or a graduate student QTT shall be reviewed and signed by the clinical supervisor within 14 days of the development of the plan or the next treatment plan review, whichever is earlier. DHS 75.24(13)(f)(f) The content of the treatment plan shall describe the identified needs and specify individualized treatment goals that are expressed in behavioral and measurable terms. DHS 75.24(13)(g)(g) The treatment plan shall specify each intervention applied to reach the treatment goals. DHS 75.24(13)(h)(h) The treatment plan shall be reviewed at the interval required by the patient’s level of care or based on the patient’s needs and clinical indication. The review shall be documented with a summary of progress and the signature of the patient and primary counselor. DHS 75.24(13)(i)(i) The treatment plan review shall include an updated level of care assessment which follows ASAM or other department-approved placement criteria and recommends continued stay, transfer, or discharge. DHS 75.24(13)(j)(j) An updated treatment plan shall be established during the review if there is a change in the patient’s needs, goals, or interventions and resources to be applied. The updated treatment plan shall be signed by the patient, the primary counselor, and any other behavioral health clinical staff identified in the treatment plan. DHS 75.24(13)(k)(k) Treatment plan reviews and updates completed by a substance abuse counselor in-training or graduate student QTT shall be reviewed and signed by the clinical supervisor within 14 days of the review and update. DHS 75.24(13)(L)(L) For patients with co-occurring disorders receiving services under ss. DHS 75.50, 75.51, 75.52, 75.54, 75.55, 75.56, and 75.59 service shall assign dually-credentialed clinicians whenever possible. When this is not possible, the service shall ensure that mental health needs and substance use needs are included in the treatment plan, and met by appropriately credentialed personnel. DHS 75.24(13)(m)(m) For a patient receiving mental health services under s. DHS 75.50 or 75.56 who does not have a co-occurring substance use disorder, the requirement for ASAM or other department-approved level of care placement criteria and review is not required. DHS 75.24(14)(a)(a) A service shall have a written policy and procedure that outlines the structure for clinical consultation. DHS 75.24(14)(b)(b) Clinical consultation applies to all clinical staff of a service. DHS 75.24(14)(c)(c) Clinical consultation shall be documented in the patient’s case record. DHS 75.24(14)(d)(d) Clinical consultation for unlicensed staff shall be completed with a clinical supervisor and shall be documented with the clinical supervisor’s signature. Clinical consultation for licensed professionals may occur with a clinical supervisor or another licensed professional who is a staff of the service. DHS 75.24(14)(e)1.1. When a patient’s substance use or mental health poses a significant risk to the individual, their family, or the community. DHS 75.24(14)(e)3.3. When an individual’s symptoms, pattern of substance use, risk level, or placement criteria indicate transfer to a higher level of care. DHS 75.24(14)(f)(f) When a safety plan requires ongoing monitoring, clinical consultation shall be completed at clinically-determined intervals until the risk level is reduced or appropriately managed with services or collateral supports. DHS 75.24(14)(g)(g) When the recommended level of care cannot be determined, or is not available, or the individual has declined the recommended level of care, clinical consultation shall be completed at clinically-determined intervals until the appropriate level of care is determined, or obtained, or the individual’s risk level decreases.